Narcotic-antagonist assay procedures in dogs.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003496:Cyclazocine / Q000494:pharmacology; D003782:Dental Pulp / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004361:Drug Tolerance; D004597:Electroshock; D006439:Hemodynamics / Q000187:drug effects; D007422:Intestines / Q000187:drug effects; D008614:Meperidine / Q000037:antagonists & inhibitors; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009269:Nalorphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010423:Pentazocine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012026:Reflex, Stretch / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013116:Spinal Cord / Q000502:physiology; D014839:Vomiting / Q000139:chemically induced
D000700:Analgesics; D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D008614:Meperidine; D003496:Cyclazocine; D010423:Pentazocine; D009269:Nalorphine